| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Aselage Steve is a Director at TVTX, with reported holdings spanning 2 companies. Recent filings cover 5 purchases and 42 sales. Those positions are worth an estimated $3.2M at current prices.
Our model assigns Aselage Steve a strong insider score of 80/100, based on 10 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +20.1%.
Aselage Steve's largest disclosed position is in TVTX as Director, worth about $3.2M. The recent filings there lean toward selling, a net 343,789 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2019 | BCRX Biocryst Pharmaceuticals Inc | Director | Buy | 15,000 | $1.45 | $21,750.00 | +224.8% | |
| May 22, 2019 | BCRX Biocryst Pharmaceuticals Inc | Director | Buy | 3,000 | $3.57 | $10,710.00 | +150.0% | |
| May 15, 2019 | TVTX Travere Therapeutics, Inc. | Director | Sell | 3,676 | $17.81 | $65,451.18 | -1.4% | |
| Mar 12, 2019 | BCRX Biocryst Pharmaceuticals Inc | Director | Buy | 2,000 | $8.30 | $16,600.00 | New | |
| Feb 12, 2019 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 2,130 | $21.44 | $45,667.20 | -0.8% | |
| Dec 21, 2018 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 12,376 | $21.88 | $270,787.85 | -4.5% | |
| Dec 7, 2018 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 10 | $24.04 | $240.37 | - | |
| Nov 15, 2018 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 11,100 | $24.03 | $266,703.42 | -4.2% | |
| Aug 31, 2018 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 12,000 | $32.00 | $384,000.00 | -4.7% | |
| Jun 14, 2017 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Buy | 5,000 | $17.85 | $89,250.00 | +2.1% |